124 related articles for article (PubMed ID: 17448959)
1. Risk assessment in haematopoietic stem cell transplantation: the liver as a risk factor.
Carreras E
Best Pract Res Clin Haematol; 2007 Jun; 20(2):231-46. PubMed ID: 17448959
[TBL] [Abstract][Full Text] [Related]
2. The use of laparoscopic liver biopsies in pediatric patients with hepatic dysfunction following allogeneic hematopoietic stem cell transplantation.
Choi SW; Islam S; Greenson JK; Levine J; Hutchinson R; Yanik G; Teitelbaum DH; Ferrara JL; Cooke KR
Bone Marrow Transplant; 2005 Nov; 36(10):891-6. PubMed ID: 16184184
[TBL] [Abstract][Full Text] [Related]
3. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
Knöll A; Boehm S; Hahn J; Holler E; Jilg W
J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
[TBL] [Abstract][Full Text] [Related]
4. Abnormal liver enzymes two years after haematopoietic stem cell transplantation in children: prevalence and risk factors.
Bresters D; Van Gils IC; Dekker FW; Lankester AC; Bredius RG; Schweizer JJ
Bone Marrow Transplant; 2008 Jan; 41(1):27-31. PubMed ID: 17994124
[TBL] [Abstract][Full Text] [Related]
5. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
Hammond SP; Borchelt AM; Ukomadu C; Ho VT; Baden LR; Marty FM
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1049-59. PubMed ID: 19660717
[TBL] [Abstract][Full Text] [Related]
7. The natural history of hepatitis C cirrhosis after liver transplantation.
Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
[TBL] [Abstract][Full Text] [Related]
8. Haematopoietic stem cell transplantation: current status.
Kumar L
Natl Med J India; 2007; 20(3):128-37. PubMed ID: 17867617
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B virus reactivation in patients with HBs antibodies after allogeneic hematopoietic stem cell transplantation].
Fujimaki K; Nakaseko C; Oshima K; Sakai M; Chou R; Kanda Y; Nishimura M; Kanamori H; Sakamaki H
Rinsho Ketsueki; 2007 May; 48(5):386-90. PubMed ID: 17571583
[TBL] [Abstract][Full Text] [Related]
11. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
Stock PG; Fung J
Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
[No Abstract] [Full Text] [Related]
12. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Karakan T; Akyol G
Bone Marrow Transplant; 2008 Oct; 42(7):461-7. PubMed ID: 18604240
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C.
Burra P
Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
[TBL] [Abstract][Full Text] [Related]
14. Risk assessment in haematopoietic stem cell transplantation: viral status.
Ljungman P
Best Pract Res Clin Haematol; 2007 Jun; 20(2):209-17. PubMed ID: 17448957
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
16. The A-B-C of haematopoietic stem cell transplantation.
Rafeah NT; Fadilah SA
Med J Malaysia; 2009 Mar; 64(1):94-100; quiz 101. PubMed ID: 19852335
[TBL] [Abstract][Full Text] [Related]
17. Living donor liver transplantation for hepatitis B cirrhosis.
Karasu Z; Akyildiz M; Kilic M; Zeytunlu M; Aydin U; Tekin F; Yilmaz F; Ozacar T; Akarca U; Ersoz G; Gunsar F; Ilter T; Lucey MR
J Gastroenterol Hepatol; 2007 Dec; 22(12):2124-9. PubMed ID: 18031369
[TBL] [Abstract][Full Text] [Related]
18. Searching for alternative hematopoietic stem cell donors for pediatric patients.
Rocha V; Locatelli F
Bone Marrow Transplant; 2008 Jan; 41(2):207-14. PubMed ID: 18084331
[TBL] [Abstract][Full Text] [Related]
19. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
[TBL] [Abstract][Full Text] [Related]
20. Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health.
Sacchi N; Costeas P; Hartwell L; Hurley CK; Raffoux C; Rosenmayr A; Greinix H;
Bone Marrow Transplant; 2008 Jul; 42(1):9-14. PubMed ID: 18362904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
